ZBIO
Zenas BioPharma, Inc.
$28.24
-1.17 (-3.98%)
At close · Jul 16
Going-concern doubt
— cleared May 13, 2026
The latest filing states the doubt was alleviated.
“During the first quarter of 2026, the Company alleviated the uncertainty associated with its ability to continue as a going concern through the execution of its senior secured term loan, the issuance of convertible senior notes and the concurrent equity offering”View the 10-Q filed May 13, 2026
Market Cap
$1.78B
Shares
63,133,377
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-06-30 | 52,399 | $25.55 | $1,338,794 |
| 2026-06-29 | 35,787 | $25.87 | $925,810 |
| 2026-06-26 | 13,338 | $24.67 | $329,048 |
| 2026-06-24 | 1,442 | $20.21 | $29,143 |
| 2026-06-18 | 11 | $18.58 | $204 |
| 2026-06-15 | 2,450 | $19.80 | $48,510 |
| 2026-06-12 | 2,692 | $17.76 | $47,810 |
| 2026-06-10 | 27 | $18.42 | $497 |
| 2026-06-09 | 42,881 | $17.61 | $755,134 |
| 2026-05-22 | 34 | $19.84 | $675 |
| 2026-05-21 | 528 | $19.56 | $10,328 |
| 2026-05-14 | 760 | $19.93 | $15,147 |
| 2026-04-28 | 11 | $18.59 | $204 |
| 2026-04-27 | 21 | $18.19 | $382 |
| 2026-04-24 | 5,585 | $18.49 | $103,267 |
| 2026-04-17 | 3,209 | $21.76 | $69,828 |
Showing 1–16 of 16 settlements